TrumpRx drug prices 2026: Johnson & Johnson Joins Program
In a significant development for American healthcare, pharmaceutical giant Johnson & Johnson has officially announced its participation in the federal TrumpRx drug prices 2026 initiative. This partnership marks the first time a major industry player has joined the platform to list its medications, signaling a potential shift in how prescription drug costs are managed for millions of Americans. As healthcare affordability remains a top priority for those on Medicare and Medigap, this collaboration is being watched closely by patients, caregivers, and policymakers alike.
What Is the TrumpRx Initiative?
TrumpRx.gov is the official federal platform launched in early 2026, designed to combat high medication costs by implementing a "Most-Favored-Nation" (MFN) p...